SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001558370-22-004750
Filing Date
2022-03-30
Accepted
2022-03-30 16:19:32
Documents
13
Period of Report
2022-03-30
Items
Item 2.02: Results of Operations and Financial Condition
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K agrx-20220330x8k.htm   iXBRL 8-K 37741
2 EX-99.1 agrx-20220330xex99d1.htm EX-99.1 212143
  Complete submission text file 0001558370-22-004750.txt   385693

Data Files

Seq Description Document Type Size
3 EX-101.SCH agrx-20220330.xsd EX-101.SCH 3181
4 EX-101.LAB agrx-20220330_lab.xml EX-101.LAB 15932
5 EX-101.PRE agrx-20220330_pre.xml EX-101.PRE 10136
7 EXTRACTED XBRL INSTANCE DOCUMENT agrx-20220330x8k_htm.xml XML 4858
Mailing Address 500 COLLEGE ROAD EAST SUITE 310 PRINCETON NJ 08540-6635
Business Address 500 COLLEGE ROAD EAST SUITE 310 PRINCETON NJ 08540-6635 609-683-1880
AGILE THERAPEUTICS INC (Filer) CIK: 0001261249 (see all company filings)

IRS No.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-36464 | Film No.: 22786716
SIC: 2834 Pharmaceutical Preparations